Insight

Winette van der Graaf/LinkedIn

Sep 5, 2025, 15:59

Winette van der Graaf: Insights from The Cancer Drug Development Forum Workshop on Rare Cancers

Winette van der Graaf, President of the EORTC and Professor of Medical Oncology at The Netherlands Cancer Institute, shared a post on LinkedIn:

“Last year the The Cancer Drug Development Forum (CDDF) held a workshop on Rare Cancers to which many stakeholders (patients, clinicians, regulators, investigators from the biomedical field, quality of life researchers, pharma, clinical trial organizations) contributed. It shows how challenging the road to precision oncology is, but also where potential solutions can be found, where and how some are in place, and where others still need a lot of support and push.”

Title: Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action

Authors: Winette T.A. van der Graaf, Nina S. Heiss, Carolyn L. Hynes, Simone P. Keller, Ariane Weinman, Jean-Yves Blay, Pedro Franco, Rachel H. Giles, Denis Lacombe, Philipp Schlatter, David M. Thomas, Sahar Barjesteh van Waalwijk van Doorn-Khosrovan, Max Williamson, Ruth Plummer

Read the Full Article.

Winette van der Graaf

Ariane Weinman Carolyn L. Hynes David M. Thomas Denis Lacombe Jean-Yves Blay Max Williamson Nina S. Heiss Pedro Franco Philipp Schlatter Rachel H. Giles Ruth Plummer Sahar Barjesteh van Waalwijk van Doorn-Khosrovan Simone P. Keller Winette T.A. van der Graaf Winette van der Graaf

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC